These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. [Eye diseases due to herpesvirus. (Herpesvirus hominis, varicella-zoster virus)]. Frezzotti R; Guerra R G Mal Infett Parassit; 1971 Jul; 23(7):689-729. PubMed ID: 4334709 [No Abstract] [Full Text] [Related]
25. Differences in natural and recombinant interferon for herpes keratitis in two animal models. Sanitato JJ; Varnell ED; Kaufman HE; Raju VK Invest Ophthalmol Vis Sci; 1984 Jul; 25(7):874-6. PubMed ID: 6735652 [TBL] [Abstract][Full Text] [Related]
26. Optimal schedules for use of interferon in the corneas of rabbits with herpes simplex keratitis. McGill JI; Collins P; Cantell K; Jones BR; Finter NB J Infect Dis; 1976 Jun; 133 Suppl():A13-7. PubMed ID: 932500 [TBL] [Abstract][Full Text] [Related]
27. Protection by polyinosinic-polycytidylic acid complex of rabbit eye tissue cultures infected with herpes simplex virus. Effect of neomycin and virus challenge dose. Weissenbacher M; Galin MA; Chowchuvech E; Schachter N; Baron S Invest Ophthalmol; 1970 Nov; 9(11):857-64. PubMed ID: 4320791 [No Abstract] [Full Text] [Related]
28. Optimal usage of exogenous human interferon for prevention or therapy of herpetic keratitis. McGill JI; Cantell K; Collins P; Finter NB; Laird R; Jones BR Trans Ophthalmol Soc U K (1962); 1977 Jul; 97(2):324-6. PubMed ID: 273343 [No Abstract] [Full Text] [Related]
30. [Molecular approach to the mechanism and treatment of herpesvirus keratitis]. Bellows JG Klin Monbl Augenheilkd; 1969; 155(5):696-706. PubMed ID: 4312942 [No Abstract] [Full Text] [Related]
31. Quantitation of herpes simplex virus in rabbit corneal epithelium. Zamansky GB; Lee BP; Chang RK; Hendricks K; Ryan WJ; Leibowitz HM Invest Ophthalmol Vis Sci; 1985 Jun; 26(6):873-6. PubMed ID: 2989209 [TBL] [Abstract][Full Text] [Related]
32. [Clinical observation on the local treatment of viral keratoconjunctivitis using leukocytic interferon and immunoglobulins]. de'Gennaro G; Gabai R Bull Mem Soc Fr Ophtalmol; 1982; 94():133-6. PubMed ID: 6191810 [No Abstract] [Full Text] [Related]
33. Endothelial lesions of rabbit cornea produced by herpes simplex virus. Oh JO Invest Ophthalmol; 1970 Mar; 9(3):196-205. PubMed ID: 4313569 [No Abstract] [Full Text] [Related]
34. [Studies on the rule of secretory immunoglobulin in the recurrent infection with herpes simplex virus]. Asai S Gifu Shika Gakkai Zasshi; 1979 Dec; 7(2):146-52. PubMed ID: 233020 [No Abstract] [Full Text] [Related]
35. [Possibilities of treatment of human herpetic keratitis with an inducer of the interferon system]. Guerra R; Frezzotti R; Bonanni R; Rita G; Dianzani F Atti Accad Fisiocrit Siena Med Fis; 1968; 17(2):1513-7. PubMed ID: 5759916 [No Abstract] [Full Text] [Related]
36. Current therapy of herpes simplex virus infection of the cornea. Laibson PR Int Ophthalmol Clin; 1973; 13(4):39-52. PubMed ID: 4361432 [No Abstract] [Full Text] [Related]
37. Human fibroblast interferon in treatment of viral diseases of the skin and mucous membranes. Isacsohn M; Berson B; Sternberg I; Morag A Isr J Med Sci; 1983 Nov; 19(11):959-62. PubMed ID: 6319325 [TBL] [Abstract][Full Text] [Related]
38. Photodynamic inactivation in the treatment of experimental herpes simplex keratitis. Thomas JV; Dunlap WA; Rich AM Br J Ophthalmol; 1973 May; 57(5):336-8. PubMed ID: 4351680 [No Abstract] [Full Text] [Related]
39. Interferon in treatment of dendritic keratitis in humans: a preliminary report. Sundmacher R; Neumann-Haefelin D; Manthey KF; Müller O J Infect Dis; 1976 Jun; 133 Suppl():A160-4. PubMed ID: 180197 [TBL] [Abstract][Full Text] [Related]